PREDICTING CORRELATION OBESITY AMONG PEOPLE WITH SCHIZOPHRENIA ON THE POWER OF PSYCHIATRIC DRUGS, NEGATIVE SYMPTOMS, POSITIVE SYMPTOMS, AND STRESS
Article Sidebar
Main Article Content
Abstract
Objectives: To study the correlation prediction of psychiatric drugs, negative symptoms, positive symptoms, and stress on obesity among people with schizophrenia.
Materials and methods: The samples of this predictive correlational research consisted of 123 patients who had been diagnosed by doctors as having schizophrenia (F20) based on ICD-10 diagnostic criteria, had been receiving continuous antipsychotic medication for six months or more, were aged between 18 and 60 years, and were not in the acute phase of severe schizophrenia at the outpatient department of a hospital in Nakhon Sawan province. Data were collected using a demographic questionnaire, an obesity assessment form, the Positive and Negative Syndrome Scale (PANSS), and the Perceived Stress Scale (PSS10). Data analysis was performed using descriptive statistics and multiple logistic regression analysis.
Results: The findings revealed that 59.3 percent of the samples were obese. The multiple logistic regression analysis revealed that the factors predicting the relationship with obesity occurrence in schizophrenic patients, statistically significant at the 0.05 level, were positive symptoms (β = -.548, OR .578, 95%CI = .469 - .713, p < 0.05) and negative symptoms (β = .483, OR 1.620, 95%CI = 1.361 – 1.929, p < 0.05)
Conclusion: Schizophrenia patients are often overweight. Therefore, providing information on managing both negative and positive symptoms of mental health patients can be a strategy to reduce risk factors for obesity, which may lead to the development of a set of symptoms known as metabolic syndrome.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความหลังผ่านการปรับแก้จากกองบรรณาธิการแล้ว เป็นลิขสิทธ์ของวารสารจิตเวชวิทยาสาร โรงพยาบาลสวนปรุง กรมสุขภาพจิต กระทรวงสาธารณสุข ห้ามเผยแพร่เพื่อประโยชน์ทางการค้าโดยไม่ได้รับอนุญาต แต่อนุญาตให้เผยแพร่บทความดังกล่าวเพื่อประโยชน์ทางการศึกษาแก่ประชาชนทั่วไป ทั้งนี้กองบรรณาธิการไม่จำเป็นต้องเห็นด้วยกับบทความหรือข้อคิดเห็นใดๆ ที่ปรากฏในวารสารสวนปรุง
References
World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO Version for; 2016. [Internet]. 2016[2022 February 14]. Available from: https://icd.who.int/browse10/2016/en#/F20-F29
World Health Organization. Obesity and Overweight. [Internet]. 2019[2022 February14]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
National Institute of Mental Health. Schizophrenia. [Internet]. 2018[2018 May 22]. Available from: https://www.nimh.nih.gov/ health/topics/schizophrenia
Health Data Center (HDC). Mental Health Data Repository for Health Region
[Internet]. 2021[2021 June 18]. Available from: https://hdcservice.moph.go.th/hdc/reports
/report.php?source=pformated/format1.php&cat_id=62974985551cfc5ebe4aca837fe9937c&id=31ad3425df7840afe354735d7d2ba957
World Health Organization. Obesity. [Internet]. 2021[2021 June 9]. Available from: https://
www.who.int/news-room/facts-ipictures/detail/6-facts-on-obesity
Gurpegui M, Martinez-Ortega JM, Gutierrez-Rojas L, Rivero J, Rojas C, Jurado D. Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample. Prog Neuropsychopharmacol Biol Psychiatry[Internet]. 2012 [2022 February 14];37:169-175. Available from: https://doi.org/10.1016/j.pnpbp.2012.01.014
Janssen EM, McGinty EE, Azrin ST, Juliano-Bult D, Daumit GL. Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness. Gen Hosp Psychiatry[Internet]. 2015 [2022 February 14];37:199-222. Available from: https://
doi.org/10.1016/j.genho sppsych.2015.03.004 26
Haw C, Rowell A. Obesity and its complications: A survey of inpatients at a secure psychiatric hospital. The British Journal of Forensic Practice[Internet]. 2011 [2022 February 14];13:270-277. Available from: doi:10.1108/14636641111190033
Tian Y, Liu D, Wang D, Wang J, Xu H, Dai Q, et al. Obesity in Chinese patients
with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits. Schizophrenia research[Internet]. 2020 [2022 February 14];215:270-276. Available from: https://doi.org/10.1016/j.schres.2019.10.017
Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol[Internet]. 2014 [2022 February 14];10:425-448. Available from: https://doi.org/10.1146/annurev-clinpsy-032813-153657
Lakkanasirorat M, Ongpalakorn C, Lukkanawiwat J, Negkaphat P, Wongyoungsil S. The prevalence diabetes mellitus and hypertension in psychiatric patients. The 6th Seoul International Congress of Endocrinology and Metabolism, SICEM[Internet]. 2018 [2022 February 14];038.
Monhkolpitaksuk J, Unaharassamee W, Sudthanaphan K, Sukontavaree C. The prevalence and associating factors with obesity in thai patients with schizophrenia at somdet chaopraya institute of psychiatry. J Psychiatr Assoc Thailant[Internet]. 2012 [2022 February 14];57:137-150.(In Thai)
Khamchata L, Dumrongpakapakorn P, Theeranut A. Metabolic Syndrome: Dangerous
signs required management. Srinagarind Medical Journal[Internet]. 2018 [2022 February 14];33: 386-95.
Institute of Medical Research and Technology Assessment. Preventing and Managing Obesity: Practical Healthcare Guidelines. The agricultural cooperative assembly in Thailand[Internet]. 2010 [2022 February 20]; Available from: http://www.imrta.dms.moph.
go.th/imrta/images/pdf_cpg/2553/53-4.pdf
Cameron IM, Hamilton RJ, Fernie G, MacGillivray SA. Obesity in individuals with schizophrenia: a case controlled study in Scotland. BJPsych Open[Internet]. 2017 [2022 February 20];3:254-256. Available from: https://doi.org/10.1192/bjpo.bp.116.003640
Subramaniam M, Lam M, Guo ME, He VYF, Lee J, Verma S, et al. Body
Mass Index, Obesity, and Psychopathology in Patients With Schizophrenia. Clinical Psychopharmacology[Internet]. 2014 [2023 January 20];34:40-46. Available from:
1097/ JCP.0000000000000058
Santo dos MM, Cabral SDMR, Mascarenhas MDM, Santos RM, Eulálio JML. Overweight and the use of psychiatric drugs in patients with mental disorders attended at psychosocial care center in Teresina, Piauí, Brazil. Nutr Hosp[Internet]. 2016 [2023 January 25];33: 838-841. Available from: http://dx.doi.org/10.20960/nh.378
Mainar AS, Maurino J, Ruiz-Beato E, Navarro-Artieda R. Prevalence of metabolic
syndrome according to the presence of negative symptoms in patients with schizophrenia. Neuropsychiatric Disease and Treatment[Internet]. 2014 [2023 January 25];11:51-57. Available from: https://doi.org/10.2147/NDT.S75449
Mezquida G, Savulich G, Garcia-Rizo C, Garcia-Portilla MP, Toll A, Garcia-Alvarez L, et al. Inverse association between negative symptoms and body mass index in chronic schizophrenia. Schizophr Res[Internet]. 2018 [2023 January 20];192:69-74. Available from: 10.1016/j.schres.2017.04.002.
Kassem M, Haddad C, Daccache C, Hayek C, Hallit S, Kazour K. Factors Associated with overweight and obesity in Lebanese male patients with schizophrenia. Perspectives in Psychiatric Care[Internet]. 2020 [2023 January 20];57:1347-1355. Available from: https://doi.org/10.1111/ppc.12697
Boontein P, Anuritprasert B, Saneha C. Factors related to metabolic Syndrome among patient at out-patient department. J NURS SCI[Internet]. 2018 [2023 January 20];35:74-86. Available from: https://he02.tci-thaijo.org/index.php/ns/article/view/116186/89497
Boonsaeng V, Nookaew S, Sinawet P, Chandrachot K, Khuean U. Guidelines for continuous monitoring and care of patients with substance/alcohol use disorder and mental health issues. Bangkok: Prosperous plus; 2020.
Nilchaikovit T, Karnjanathanalers N, Srisurapanont M, Ounanong S, Udomratn P. Positive and negative syndrome scale(PANSS-T). Bangkok: Janssen cilag; 2007.
Wongpakaran N, Wongpakaran T. The Thai version of the PSS-10: An Investigation of its psychometric properties. BioPsychoSocial med[Internet]. 2010 [2023 January 20]; 4:1-6. Available from: 10.1186/1751-0759-4-6.
Janney CA, Ganguli R, Richardson CR, Holleman RG, Tang G, Cauley JA, et al.
Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST Study). Schizophrenia Research
[Internet]. 2013 [2023 January 20];145:63-68. Available from: 10.1016/j.schres.2013.01.010
Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with
schizophrenia. Psychological Medicine[Internet]. 1999 [2023 January 25];29:697-701. Available from: 10.1017/S0033291798008186
Pongsripiyakul U. Guidelines for Rational Drug Use in Psychiatric Medicine According to the National List of Essential Medicines. National Drug Committee; 2015. (In Thai)
Kassm SA, Hoertel N, Naja W, McMhon K, Barriere S, Blumenstock Y, et al.
Metabolic syndrome among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study. Psychiatry Research[Internet]. 2019 [2023 January 29];275:238-246. Available from: https://doi.org/10.1016/j.psychres.2019.03.036
Department of Mental Health. Stress Relief Handbook. 2ed. Nonthaburi: Siam M&B Printing; 1998. (In Thai)
Chaichanasa S. Factors Affecting Progress in the Care of Family Members with Mental Illness. Sri Thanaya Hospital Journal[Internet]. 1993 [2023 January 29];1:15-16.(In Thai)
Department of Mental Health. Stress Categories Impacting Health. [Internet]. 2020
January 29]. Available from: https://dmh.go.th/news-dmh/view.asp?id=30321
Sun MJ, Jang MH. Risk Factors of Metabolic Syndrome in Community-Dwelling People with Schizophrenia. International Journal of Environmental Research and Public Health
[Internet]. 2020 [2023 January 25];17:6700. Available from: doi:10.3390/Ijerph17186700